✦ LIBER ✦
In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance
✍ Scribed by Michael J. Bloch; Jan N. Basile
- Book ID
- 114899111
- Publisher
- Le Jacq Communications, Inc.
- Year
- 2010
- Tongue
- English
- Weight
- 246 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1524-6175
No coin nor oath required. For personal study only.